Surgical Drainage Devices Market

Market Overview

The global surgical drainage devices market size was valued at USD 2.76 billion in 2022. It is projected to reach USD 4.65 billion by 2031, growing at a CAGR of 6.75% during the forecast period (2023-2031).

Surgical drainage devices remove the contents of various organs, bodily secretions, blood, serum, lymph, and other tissue fluids collected in surgical wound beds after operations. These tools reduce pressure on the surgery site and surrounding organs, nerves, and blood vessels, which lessens discomfort and speeds up wound healing. They are used in infected cysts, chest drainage, nasogastric tubes, and urinary catheters. Depending on the patient's surgery and wound, a variety of surgical drainage devices composed of latex, silicone, polyethylene, and polyvinyl chloride (PVC) are currently offered worldwide.

Highlights

• Active surgical drainage devices dominate the product segment.
• Thoracic and cardiovascular surgeries dominate the application segment.
• Hospitals dominate the end-user segment.
• North America is the most significant shareholder in the global market.

Market Dynamics

Global Surgical Drainage Devices Market Drivers:

Growing Number of Surgical Procedures

One of the main drivers of the market growth is the sharp rise in surgical procedures involving the thyroid, lymph nodes, breast, abdomen, and chest. Surgical drainage devices aid in healing by eliminating bacteria, foreign objects, inflammatory mediators, and necrotic tissues. Due to people's increased willingness to have reconstructive and cosmetic procedures, there is an increasing demand for plastic surgery, driving the market growth. In addition, surgical drainage devices monitor possible issues and release the pressure that could hinder perfusion or cause pain, lowering morbidity. Therefore, the increasing prevalence of orthopedic surgeries linked to blood loss and neurosurgery with a significant risk of elevated intracranial pressure impacts the market's growth.

Surgical drainage devices are also commonly used in animal medicine to address surgical or traumatic wounds. The expanding popularity of companion animals fuels market expansion and the booming poultry and agricultural industries. The market is also projected to be driven by the increased emphasis on enhancing functionality and lowering difficulties related to drainage devices used in surgeries.

Increasing Demand for Medical Tourism

Patients can receive affordable surgical procedures closely monitored by medical professionals because medical tourism is becoming more popular in nations like Brazil, India, Turkey, and Malaysia. Due to the extremely low cost of surgeries in these nations, people from the United States and Europe visit there. For instance, a single laparoscopy costs between USD 500 and USD 1,100 in India, whereas the same surgery costs between USD 5,000 and USD 10,000 in the United States. This is also anticipated to accelerate the market expansion for surgical drainage devices in these nations.

Global Surgical Drainage Devices Market Restraint:

Lack of Clinical Knowledge and Expertise

A solid clinical foundation is essential for the success and efficiency of extensive surgical procedures. Lack of expertise and experience is problematic for many reasons. For instance, if there is a limited understanding of where to position surgical drainage devices, there may be a risk of a leak between the drain tube and the surgical site. The possibility of wound infection is also raised when the dressing is placed incorrectly.

Global Surgical Drainage Devices Market Opportunities:

Increasing investment of Leading Players in the Development of Innovative Products

Modern surgical drainage devices are being introduced to the market by manufacturers to meet unmet patient needs, offering both seasoned competitors and newcomers promising opportunities. For example, the Mayo Foundation and Medical Education and Research introduced surgical drain line stripping devices in April 2018. I-Inspire LLC released a surgical drain management tool (post-surgical drain management punch) in March 2018, and Spectral Spine IP Holdings, LLC released a surgical drain system in August 2017. According to the American Heart Association, there were 17.3 million deaths worldwide due to cardiovascular illnesses in 2016, and by 2030, it is predicted that there will be 23.3 million fatalities due to CVDs.

Additionally, medical technology businesses are concentrating on making strategic acquisitions to broaden their product line and improve chances in non-U.S. clinical sectors seeing rapid growth. For instance, in April 2017, global medical technology company Becton, Dickinson and Company (BD) and medical technology leader in urology, oncology, and surgical specialty products Bard, Inc., entered into an agreement under which BD will acquire Bard for USD 24 billion in cash and stock, or USD 317 per Bard common share. This acquisition will help patients and healthcare professionals receive better care and illness treatment.

Regional Analysis

Based on region, the global surgical drainage devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America Dominates the Global Market

North America is the most significant global surgical drainage devices market shareholder and is expected to grow significantly over the forecast period. The segment held a revenue share of 40.84% in 2022. Elderly people are more likely to develop chronic wounds; in the US, people over 65 account for about 3% of people with open wounds. In the United States, there are more than 55 million people aged 65 or over, and 2% of the population is thought to be affected by chronic wounds, according to predictions from the 2020 Census Bureau. The need for surgical drainage devices is directly impacted by the region's increasing rates of chronic and open wounds. In addition, an increase in surgeries in the area is another significant element driving up demand for surgical drainage devices.

In Canada, over a million procedures are performed annually. Thus, the need for surgical drainage devices and the number of procedures is rising. In addition, there are more than 7,000 hospitals in North America, and the local administrations are heavily funding the construction of new medical institutions. Therefore, it is anticipated that there will be an increase in demand for surgical drainage devices in the region due to the establishment of new healthcare facilities.

Asia-Pacific is expected to grow at a CAGR of 6.2% during the forecast period. The high need for advanced wound care products in several Asian countries, the growing geriatric population, an increase in surgical procedures, an increase in the prevalence of chronic wounds and wounds caused by diabetes, and the focus of major players on expanding their presence in this region are some of the primary factors driving the growth of the surgical drains market in Asia-Pacific.

Segmental Analysis

The global surgical drainage devices market is segmented into product, application, and end-user.

Based on the product, the global market is bifurcated into active and passive.

The active surgical drainage devices segment is the highest contributor to the market. The segment held the largest share of 67.06% in 2022. These devices use suction, either vacuum or wall suction, to remove fluid and avoid the buildup of air at the surgical site. Active surgical drainage devices frequently use negative pressure therapy to drain fluid from the operative site. The drain chosen by the surgeon is specific to the procedure being performed. Since active drains are sealed off from the environment, bacteria cannot flourish there. They are skilled at effectively draining fluid from the incision and keeping it dry. For instance, Medtronic created the Altitude Dry Suction Chest Drainage Unit, which uses wall suction to remove collected fluid during thoracic and cardiovascular procedures.

Based on application, the global market is segmented into orthopedics, neurosurgery, abdominal surgery, and other surgical procedures.

Thoracic and cardiovascular surgeries accounted for the largest share of over 28.04% in 2022. This is due to an increase in cardiovascular disease prevalence. According to the WHO, cardiovascular illnesses, the leading cause of mortality worldwide, claimed an estimated 17.9 million lives in 2019. This has increased the demand for chest drainage systems that efficiently and painlessly drain fluid from the chest. The increased use of surgical drainage devices created expressly for cardiovascular surgeries results from an increase in the number of operations being done. For instance, Teleflex Incorporated's Pleur-evac Chest Drainage System is a tool that helps with effective fluid drainage during thoracic and cardiovascular procedures.

In addition, the third and sixth most common causes of mortality in the US, respectively, are stroke and Alzheimer's disease, according to the American Academy of Neurology. These statistics show a worrying rise in neurological illnesses, many requiring surgery after diagnosis. Therefore, this rise has contributed to the demand for drains used during neurosurgical procedures.

Based on end-user, the global market is segmented into hospitals, ambulatory surgical centers, and clinics.

The hospital segment is the highest contributor to the market. The segment held the largest share of over 41.02% in 2022 due to a large number of surgeries conducted. A global increase in ambulatory surgical centers is another crucial factor contributing to the market growth. In addition, specialty clinics have expanded significantly due to their capacity to offer services specifically tailored to patients' needs. Therefore, the expansion of this market has been made possible by the increasing use of surgical drainage devices.

Recent Developments

• October 2021- Centese developed a self-cleaning chest tube system that provides more precise measures for monitoring patients recovering from heart or lung surgery. The Thoraguard device is the one that Centese invented.

• April 2019- Smith & Nephew plc stated that it had acquired Osiris Therapeutics, Inc. This addition will develop the wound care franchise and expand Smith & Nephew's surgical drains business.